de Cos Escuin et al evaluated patients with Stage III non-small lung cancer who underwent chemoradiation. They identified a number of factors that were associated with a poor prognosis. The authors are from Hospital San Pedro de Alcantara, Clinica San Francisco, and Hospital Clinico Universitario Salamanca in Spain.